Biotech

All Articles

Biogen cans SAGE-324 collaboration after crucial shake fall short

.Biogen has conducted the last ceremonies to its own collaboration along with Sage Rehabs on SAGE-32...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel buyout ratings

.On the same time that some Parkinson's illness medications are actually being brought into question...

Arch shuts $3B-plus fund to encourage biopharma startups

.On the heels of a $3 billion fund from Bain Capital Lifestyle Sciences, Arc Project Allies is actua...

Orion to utilize Aitia's 'electronic doubles' to find brand-new cancer medications

.Finnish biotech Orion has actually snooped potential in Aitia's "digital identical twin" technician...

Windtree's shock med brings up high blood pressure in most recent stage 2 gain

.While Windtree Therapies has actually battled to develop the financial origins required to make it ...

2 cancer cells biotechs merge, generating worldwide footprint

.OncoC4 is taking AcroImmune-- and also its own in-house medical manufacturing abilities-- under its...

Amgen records initial stage 3 gain for $400M eczema medicine

.Amgen has discussed (PDF) the first period 3 records on its own $400 million chronic eczema medicat...

Biogen, UCB record period 3 lupus gain after falling short earlier trial

.Biogen and UCB's rely on developing right into stage 3 astride a broken study hopes to have paid of...

Aptadir really hopes brand new RNA inhibitors can easily turn around complicated cancers

.Italian biotech Aptadir Rehabs has actually introduced with the guarantee that its pipeline of prec...

Wave surfs DMD results to regulators' doors, sending stock up

.Wave Lifestyle Sciences has satisfied its target in a Duchenne muscular dystrophy (DMD) study, inst...